Dextech Medical AB Income Statement

Financials in millions SEK. Fiscal year is July - June.

Millions SEK. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	4.15	3.22	5.39	8.71	3.12	0.63
Revenue Growth	-2.03%	-40.15%	-38.18%	179.60%	390.65%	6.48%
Gross Profit	4.15	3.22	5.39	8.71	3.12	0.63
Depreciation & Amortization Expenses	-	4.21	3.69	-	3.03	4.13
Other Operating Expenses	10.5	8.54	10.93	13.65	8.39	6.71
Total Operating Expenses	10.5	12.76	14.62	13.65	11.41	10.84
Operating Income	-4.77	-5.32	-5.55	-4.94	-8.3	-10.2
Total Non-Operating Income (Expense)	0.15	-	-	0.35	-5.27	-6.08
Pretax Income	-6.12	-4.84	-4.71	-4.59	-5.27	-6.08
Net Income	-1.73	-4.84	-4.71	-4.59	-5.27	-6.08
Net Income to Common	-1.73	-4.84	-4.71	-4.59	-5.27	-6.08
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	4,635	19	19	18	17	15
Shares Outstanding (Diluted)	4,635	19	19	18	17	15
Shares Change	-	-1.00%	2.52%	8.01%	14.72%	-0.11%
EPS (Basic)	-0.33	-0.26	-0.25	-0.25	-0.31	-0.41
EPS (Diluted)	-0.33	-0.26	-0.25	-0.25	-0.31	-0.41
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-1.33	-1.11	-0.81	-1.55	-2	-2
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.00	-0.06	-0.04	-0.08	-0.12	-0.13
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-114.88%	-165.01%	-103.04%	-56.70%	-266.36%	-1606.60%
Profit Margin	-41.66%	-150.31%	-87.38%	-52.69%	-169.14%	-956.77%
FCF Margin	-32.04%	-34.46%	-15.00%	-17.82%	-64.20%	-314.94%
EBITDA	-4.77	-5.32	-5.55	-4.94	-8.3	-10.2
EBIT	-4.77	-5.32	-5.55	-4.94	-8.3	-10.2
EBIT Margin	-114.88%	-165.01%	-103.04%	-56.70%	-266.36%	-1606.60%